Send us a text

From a lizard’s venom to Hollywood’s favorite weight-loss trend, this episode of Petri Dish Perspectives: Biotech Unleashed dives deep into the fascinating journey of GLP-1 agonists.

Discover how scientists uncovered a gut hormone that revolutionized diabetes care, led to the creation of Ozempic and Mounjaro, and sparked a cultural movement around body image and health. We’ll trace the science, the breakthroughs, and the billion-dollar race shaping the future of metabolic medicine.

🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

#GLP1 #Ozempic #Mounjaro #Wegovy #BiotechUnleashed #PetriDishPerspectives #Biotech #Pharma #DrugDiscovery #Obesity #Diabetes #MetabolicHealth #HealthcareInnovation #SciencePodcast

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

What if you could silence disease at its genetic root? That was the bold promise behind RNA interference (RNAi), one of the most groundbreaking scientific discoveries of the 21st century.

In this episode, we dive into the story of Alnylam Pharmaceuticals, from its founding by a powerhouse team of Nobel laureates, pioneering scientists, and biotech visionaries, to its transformation into the world’s first RNAi therapeutics company. We explore the challenges of turning a fragile lab discovery into medicine, the blockbuster drugs that redefined rare disease treatment, and the people who made it all possible.

Whether you’re a biotech enthusiast, a student of innovation, or just curious about how cutting-edge science becomes lifesaving therapy, this episode will take you inside the revolution that gave rise to RNAi medicines.

🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

#BiotechUnleashed #Alnylam #RNAi #BiotechPodcast #RareDisease #DrugDiscovery #BiotechHistory #GeneticMedicine

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

From its humble beginnings in 1781 as a family-run herbal medicine shop in Osaka to becoming one of the world’s top 10 pharmaceutical companies, Takeda’s story is one of resilience, reinvention, and bold transformation.

In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead unpacks Takeda’s 240-year journey, from the vision of founder Chobei Takeda, through the blockbuster eras of Prevacid and Actos, to the game-changing acquisition of Shire under CEO Christophe Weber. We’ll dive into the discovery stories behind Takeda’s most important drugs, the leaders who left their mark, and the lessons this Japanese giant offers on balancing tradition with global ambition.

Whether you’re fascinated by pharma history, curious about blockbuster drug stories, or want to understand how one company bridged centuries of medicine, this episode has it all.

🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

#Takeda #BiotechPodcast #PharmaHistory #DrugDiscovery #HealthcareInnovation #RareDiseases #BiotechUnleashed #PetriDishPerspectives

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

From secrecy and skepticism to one of the fastest vaccine rollouts in history, this episode of Petri Dish Perspectives: Biotech Unleashed dives into the remarkable journey of Moderna. We trace the company’s early hype, billion-dollar partnerships, and criticism for overpromising, through to its historic COVID-19 vaccine that changed global medicine. What’s next for Moderna beyond the pandemic? Tune in to explore how one biotech bet on mRNA and won.

Whether you’re a biotech enthusiast, a healthcare professional, or just curious about the companies that quietly keep hospitals running, this episode sheds light on why Moderna deserves your attention.

🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

#Moderna #mRNA #BiotechUnleashed #PetriDishPerspectives #COVID19Vaccine #Biotech #Pharma #DrugDevelopment #Innovation #Healthcare #Vaccines

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

Baxter may not always grab the biotech headlines, but its impact on modern healthcare is impossible to ignore. From the first commercially prepared IV solutions in the 1930s to pioneering dialysis fluids, blood systems, recombinant hemophilia therapies, and parenteral nutrition, Baxter has consistently solved medicine’s “unsexy but essential” problems.

In this episode, we dive into the company’s origins, explore the backstories of its most important innovations, and trace how it spun off biotech powerhouse Baxalta, later snapped up by Shire and Takeda. Along the way, we highlight the people who left their mark and extract key lessons from Baxter’s journey through growth, crisis, and reinvention.

Whether you’re a biotech enthusiast, a healthcare professional, or just curious about the companies that quietly keep hospitals running, this episode sheds light on why Baxter deserves your attention.

🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

https://linktr.ee/maneadkhin

Hashtags:
#BiotechUnleashed #PetriDishPerspectives #Baxter #BiotechHistory #HealthcareInnovation #Biopharma #LifeSciences #DrugDiscovery #MedicalDevices #PharmaIndustry

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead explores the remarkable journey of AstraZeneca, from its unlikely Swedish-British merger to blockbuster drugs like Nexium and Crestor, through near-decline, and ultimately its reinvention as a science-driven leader in oncology, cardiometabolic health, and global public health.

Discover how bold leadership, high-risk bets, and groundbreaking discoveries like Tagrisso, Enhertu, and Farxiga transformed AstraZeneca into one of today’s most innovative pharmaceutical giants.

Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

https://linktr.ee/maneadkhin

#AstraZeneca #BiotechUnleashed #PetriDishPerspectives #BiotechPodcast #PharmaInnovation #Oncology #CardiometabolicHealth #PrecisionMedicine #DrugDiscovery #HealthcareLeadership

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the remarkable and controversial story of Gilead Sciences, a company that redefined what medicine could achieve. From its beginnings in the late 1980s under physician-scientist Michael Riordan, Gilead transformed antiviral drug development with breakthroughs in HIV treatment, revolutionized global health with a cure for hepatitis C, and pushed into oncology with cutting-edge CAR-T therapies.

But alongside these triumphs came firestorms of criticism, from the $84,000 price tag of Sovaldi to debates around HIV drug access and patents. Gilead has long walked the fine line between lifesaving innovation and public outrage, forcing society to wrestle with the question: What is the true price of a cure?

Join us as we unpack Gilead’s origins, its blockbuster breakthroughs, its controversies, and what lies ahead for one of biotech’s most influential and polarizing companies.

Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

https://linktr.ee/maneadkhin

#Biotech #GileadSciences #HIV #HepatitisC #CART #Oncology #DrugDiscovery #Pharma #HealthcareInnovation #MedicalBreakthroughs #PetriDishPerspectives

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the story of GlaxoSmithKline (GSK), one of the world’s most influential pharma giants!

From scaling up penicillin production in WWII, to pioneering semi-synthetic antibiotics like amoxicillin, to leading the global vaccine race with Cervarix and Shingrix, GSK has left an indelible mark on modern medicine. We also explore its groundbreaking role in HIV treatment through ViiV Healthcare, and the blockbuster drugs that reshaped respiratory and infectious disease care. Along the way, we draw key lessons on adaptability, collaboration, and the power of prevention in pharma’s evolving landscape.

Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

https://linktr.ee/maneadkhin

#GSK #Pharma #Vaccines #BiotechPodcast #DrugDiscovery #HIV #Shingrix #Cervarix #Antibiotics #Asthma #PetriDishPerspectives

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.